Your browser doesn't support javascript.
loading
Hospital-treated deliberate self-poisoning patients: Drug-induced delirium and clinical outcomes.
Gale, Lindsay; McGill, Katie; Twaddell, Scott; Whyte, Ian M; Lewin, Terry J; Carter, Gregory L.
Affiliation
  • Gale L; Department of Consultation-Liaison Psychiatry, Calvary Mater Newcastle Hospital, Waratah, NSW, Australia.
  • McGill K; MH-READ, Hunter New England Mental Health Services, Newcastle, NSW, Australia.
  • Twaddell S; School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia.
  • Whyte IM; Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia.
  • Lewin TJ; School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia.
  • Carter GL; MH-READ, Hunter New England Mental Health Services, Newcastle, NSW, Australia.
Aust N Z J Psychiatry ; 56(2): 154-163, 2022 Feb.
Article in En | MEDLINE | ID: mdl-33938265
OBJECTIVE: Drug-induced delirium has been attributed to opioid, benzodiazepine, antipsychotic, antihistaminic and anticholinergic drug groups at therapeutic doses. Delirium also occurs in hospital-treated self-poisoning (at supra-therapeutic doses), although the causative drug classes are not well established and co-ingestion is common. We tested the magnitude and direction of association of five major drug groups with incident cases of delirium. METHODS: A retrospective longitudinal cohort (n = 5131) study was undertaken of deliberate and recreational/chronic misuse poisoning cases from a regional sentinel toxicology unit. We described ingestion and co-ingestion patterns and estimated the unadjusted and adjusted odds for developing a drug-induced delirium. We also estimated the odds of drug-induced delirium being associated with three outcomes: intensive care unit admission, general hospital length of stay and discharge to home. RESULTS: Drug-induced delirium occurred in 3.9% of cases (n = 200). The unadjusted odds ratios for development of delirium were increased for anticholinergics 10.79 (5.43-21.48), antihistamines 6.10 (4.20-8.84) and antipsychotics 2.99 (2.20-4.06); non-significant for opioids 1.31 (95% confidence interval = [0.81, 2.13]); and reduced for benzodiazepines 0.37 (0.24-0.58); with little change after adjustment for age, gender and co-ingestion. Delirium was associated with intensive care unit admission, longer length of stay and discharge destination. CONCLUSION: Drug-induced delirium was uncommon in this population. Co-ingestion was common but did not alter the risk. In contrast to drug-induced delirium at therapeutic doses in older populations, opioids were not associated with delirium and benzodiazepines were protective. Drug-induced delirium required increased clinical services. Clinical services should be funded and prepared to provide additional supportive care for these deliriogenic drug group ingestions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Delirium Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Aust N Z J Psychiatry Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Delirium Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Aust N Z J Psychiatry Year: 2022 Document type: Article Affiliation country: Country of publication: